- Forums
- ASX - By Stock
- MSB
- Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-7
-
-
- There are more pages in this discussion • 349 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
0.005(0.51%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
99.5¢ | $1.00 | 98.5¢ | $400.0K | 404.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 8391 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 27568 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 8391 | 0.995 |
15 | 103071 | 0.990 |
12 | 100416 | 0.985 |
17 | 250066 | 0.980 |
5 | 72012 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 27568 | 4 |
1.005 | 32016 | 8 |
1.010 | 38690 | 6 |
1.015 | 126242 | 4 |
1.020 | 75986 | 3 |
Last trade - 10.28am 15/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online